Literature DB >> 563773

In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.

C Damais, M Parant, L Chedid, P Lefrancier, J Choay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 563773     DOI： 10.1016/0008-8749(78)90137-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  16 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

2.  Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.

Authors:  J L Krahenbuhl; S D Sharma; R W Ferraresi; J S Remington
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

3.  Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; M Kiso; A Hasegawa; Y Tanio; Y Yamamura
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

4.  Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; Y Tanio; M Kiso; A Hasegawa; Y Yamamura
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs.

Authors:  H Takada; M Tsujimoto; S Kotani; S Kusumoto; M Inage; T Shiba; S Nagao; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

6.  Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

Authors:  I Saiki; Y Tanio; M Yamawaki; M Uemiya; S Kobayashi; T Fukuda; H Yukimasa; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Muramyl dipeptide is a powerful potentiator of the antitumor action of various tumor-necrotizing agents.

Authors:  N Bloksma; F M Hofhuis; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species.

Authors:  K P McAdam; N T Foss; C Garcia; R DeLellis; L Chedid; R J Rees; S M Wolff
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.

Authors:  R C Humphres; P R Henika; R W Ferraresi; J L Krahenbuhl
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.

Authors:  G M Bahr; F Z Modabber; A Morin; M Terrier; A Eyquem; L Chedid
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.